UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prucalopride induces high‐amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study

Neurogastroenterology and motility, 2016-09, Vol.28 (9), p.1341-1348

2016

Volltextzugriff (PDF)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease

Journal of blood medicine, 2022-11, Vol.13, p.649-662

2022

Volltextzugriff (PDF)

Genetic variation in DLG5 is associated with inflammatory bowel disease

Nature genetics, 2004-05, Vol.36 (5), p.476-480

2004

Volltextzugriff (PDF)

Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease

European journal of gastroenterology & hepatology, 1995-05, Vol.7 (5), p.461

1995

Volltextzugriff (PDF)

Structure−Activity Relationship of 2-[[(2-Pyridyl)methyl]thio]-1H- benzimidazoles as Anti Helicobacter pylori Agents in Vitro and Evaluation of their in Vivo Efficacy

Journal of medicinal chemistry, 1998-05, Vol.41 (11), p.1777-1788

1998

Volltextzugriff (PDF)

Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth

Biochimica et biophysica acta, 2000-03, Vol.1474 (1), p.107-113

2000

Volltextzugriff (PDF)

A comparison of oligonucleotide and cDNA-based microarray systems

Physiological genomics, 2004-02, Vol.16 (3), p.361-370

2004

Volltextzugriff (PDF)

A Rat Model of Chronic Helicobacter pylori Infection: Studies of Epithelial Cell Turnover and Gastric Ulcer Healing

Scandinavian journal of gastroenterology, 1998, Vol.33 (4), p.370-378

1998

Volltextzugriff (PDF)

Design and Synthesis of Dihydrofolate Reductase Inhibitors Encompassing a Bridging Ester Group. Evaluation in a Mouse Colitis Model

Journal of medicinal chemistry, 2003-07, Vol.46 (16), p.3455-3462

2003

Volltextzugriff (PDF)

OC 14.2 Pharmacokinetic Characteristics of ADAMTS13 in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Interim Results from a Phase 3 Randomized, Controlled, Open-Label, Crossover Study

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100531, Article 100531

2023

Volltextzugriff (PDF)

OC 14.1 Phase 3 Prospective, Randomized, Controlled, Open-Label, Multicenter, Crossover Study of Recombinant ADAMTS13 in Patients with Congenital Thrombotic Thrombocytopenic Purpura

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100533, Article 100533

2023

Volltextzugriff (PDF)

OC 14.4 Recombinant ADAMTS13 Prophylaxis in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Interim Analysis from Phase 3B Continuation Study

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.100534, Article 100534

2023

Volltextzugriff (PDF)

Anti-inflammatory effects of budesonide in intestinal epithelial cells

Pharmacological research, 2005-11, Vol.52 (5), p.422-428

2005

Volltextzugriff (PDF)

Inoculation of VacA− and CagA− Helicobacter pylori Delays Gastric Ulcer Healing in the Rat

Scandinavian journal of gastroenterology, 1997, Vol.32 (5), p.439-444

1997

Volltextzugriff (PDF)

Inoculation of VacA and CagA Helicobacter pylori delays gastric ulcer healing in the rat

Scandinavian journal of gastroenterology, 1997, Vol.32 (5)

1997

Volltextzugriff (PDF)

Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth

Biochimica et biophysica acta, Protein structure and molecular enzymology, 2000-03, Vol.1474 (1), p.107-113

2000

Volltextzugriff (PDF)

Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19

Thrombosis research, 2021-05, Vol.201, p.100-112

2021

Volltextzugriff (PDF)

1274P Performance status (PS) and end-of-life (EOL) care in patients (pts) with metastatic prostate cancer (mPC) treated with androgen receptor targeted (ART) therapy

Annals of oncology, 2022-09, Vol.33, p.S1129

2022

Volltextzugriff (PDF)

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

Discover. Oncology, 2022-08, Vol.13 (1), p.73-73, Article 73

2022

Volltextzugriff (PDF)

Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15160-e15160

2020

Volltextzugriff (PDF)

Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15068-e15068

2020

Volltextzugriff (PDF)

Risk factors for emergency room and hospital care for patients with advanced solid tumors on immune checkpoint inhibitor therapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15142-e15142

2020

Volltextzugriff (PDF)

Characterizing patterns of disease progression in patients with genitourinary cancers treated with immune checkpoint inhibitors

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.482-482

2020

Volltextzugriff (PDF)

Type, timing, and risk factors associated with immune-related adverse event development in patients with advanced genitourinary cancers treated with immune checkpoint inhibitor

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.480-480

2020

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(9)
Female
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Animals
(6)
Male
(6)
Gastroenterology & Hepatology
(5)
Middle Aged
(5)
Adult
(4)
Aged
(4)
Disease Models, Animal
(4)
Helicobacter Pylori
(4)
Inflammation
(4)
Mice
(4)
Rats
(4)
Gastroenterology. Liver. Pancreas. Abdomen
(3)
Helicobacter Pylori - Growth & Development
(3)
Other Diseases. Semiology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prucalopride induces high‐amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease

Genetic variation in DLG5 is associated with inflammatory bowel disease

Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease

Structure−Activity Relationship of 2-[[(2-Pyridyl)methyl]thio]-1H- benzimidazoles as Anti Helicobacter pylori Agents in Vitro and Evaluation of their in Vivo Efficacy

Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth

A comparison of oligonucleotide and cDNA-based microarray systems

A Rat Model of Chronic Helicobacter pylori Infection: Studies of Epithelial Cell Turnover and Gastric Ulcer Healing

Design and Synthesis of Dihydrofolate Reductase Inhibitors Encompassing a Bridging Ester Group. Evaluation in a Mouse Colitis Model

OC 14.2 Pharmacokinetic Characteristics of ADAMTS13 in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Interim Results from a Phase 3 Randomized, Controlled, Open-Label, Crossover Study

OC 14.1 Phase 3 Prospective, Randomized, Controlled, Open-Label, Multicenter, Crossover Study of Recombinant ADAMTS13 in Patients with Congenital Thrombotic Thrombocytopenic Purpura

OC 14.4 Recombinant ADAMTS13 Prophylaxis in Patients with Congenital Thrombotic Thrombocytopenic Purpura: Interim Analysis from Phase 3B Continuation Study

Anti-inflammatory effects of budesonide in intestinal epithelial cells

Inoculation of VacA− and CagA− Helicobacter pylori Delays Gastric Ulcer Healing in the Rat

Inoculation of VacA and CagA Helicobacter pylori delays gastric ulcer healing in the rat

Helicobacter pylori-antigen-binding fragments expressed on the filamentous M13 phage prevent bacterial growth

Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19

1274P Performance status (PS) and end-of-life (EOL) care in patients (pts) with metastatic prostate cancer (mPC) treated with androgen receptor targeted (ART) therapy

Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

Type, timing, and patient characteristics associated with immune-related adverse event development in patients with advanced solid tumors treated with immune checkpoint inhibitors

Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors

Risk factors for emergency room and hospital care for patients with advanced solid tumors on immune checkpoint inhibitor therapy

Characterizing patterns of disease progression in patients with genitourinary cancers treated with immune checkpoint inhibitors

Type, timing, and risk factors associated with immune-related adverse event development in patients with advanced genitourinary cancers treated with immune checkpoint inhibitor

Suchergebnisse filtern